$CLIR

ClearSign Technologies Corp (CLIR): Entry into a Material Definitive Agreement

ClearSign Technologies Corp (CLIR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 3 tm2621046d1_ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this “ Agreement ”) is entered into as of July 21, 2026, by and between ClearSign Technologies Corporation, a Delaware corporation (the “ Company ”) and Otter Capita

Original reporting
Published Jul 23, 2026, 12:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 1:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CLIR
Neutral
medium confidence
Mentioned
$CLIR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CLIRNeutralMed
01

Why it matters

A priced common stock sale to a single purchaser can affect liquidity, float, and valuation expectations. The key tradable elements are the fixed per-share price ($3.54), share count (500,000), and the scheduled closing (July 22, 2026).

02

Market read

New, priced equity issuance details are disclosed, creating a near-term dilution and financing narrative for CLIR into the closing date.

03

What to watch

Traders will want to check whether the $3.54 price is at a discount to the prior close, the company’s cash burn, and whether there are additional financing terms not included in the excerpt.

Relevance 6/10Novelty 8/10Timing: ahead of the July 22, 2026 closing of the share purchase

Background

The 8-K reports entry into a material definitive agreement and an unregistered equity issuance under Regulation D exemptions.

Company-level read

Ticker impact

$CLIRNeutralMedium confidence
Context

ClearSign entered a material definitive stock purchase agreement to sell 500,000 shares at $3.54 per share to Otter Capital.

Expected impact

Near-term downside risk from dilution, partially offset by balance-sheet cash; magnitude likely moderate given the disclosed $1.77M purchase price.

Evidence & confidence

This is a primary SEC 8-K disclosure of a priced share sale (500,000 shares at $3.54) with a stated closing date (July 22, 2026). The article does not provide use of proceeds or size versus market cap, limiting precision on price impact.

Market effects

Microcap/small-cap issuers may see read-across for financing risk, but no sector-wide regulatory or operational change is disclosed.

No specific regional market linkage beyond US-listed small-cap financing activity.

Limited global relevance; the disclosure is company-specific and small in dollar terms as presented.

Counterpoint

If the proceeds fund near-term catalysts (not disclosed here), the equity sale could be viewed as supportive rather than dilutive.

Key entities

  • ClearSign Technologies Corp

    Company entering the stock purchase agreement and selling 500,000 shares of common stock.

  • Otter Capital LLC

    Purchaser buying 500,000 shares for an aggregate $1,770,000.

Related articles

$CLIRLow

ClearSign Technologies Corporation Provides Second Quarter 2026 Update

ClearSign Technologies Corp (CLIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ClearSign Technologies Corporation Provides Second Quarter 2026 Update TULSA, Okla., August 19, 2026 – ClearSign Technologies Corporation (Nasdaq: CLIR) (“ClearSign” or the “Company”), a leader in advanced combustion and sensing technologies that help industrial oper

$CLIRMedAI 8/10

ClearSign (CLIR) Q4 2025 Earnings Transcript

ClearSign Technologies reported Q4 2025 revenue of $3.7 million versus $590,000 in Q4 2024, driven mainly by a 26-process burner order for a Gulf Coast petrochemical plant, according to CFO Brent Hinds. Full-year 2025 revenue rose 44% to $5.2 million. Gross margin was 27% (down from 31%) and the full-year net loss increased about $197,000, mainly from $746,000 in legal fees. Cash was $9.2 million.

Low

SpaceX Wants $40 Billion More to Fund Its Nvidia AI Bet

SpaceX plans to raise $40 billion, including $10 billion in bank loans and $30 billion in investment-grade debt, to fund Nvidia processor acquisitions. Apollo Global Management will lead the fundraising. SpaceX's bonds have declined due to debt concerns, and its BBB rating allows access to investment-grade buyers. The acquisition is expected to close in 2027, with investor demand and financing terms being key factors.

$RCKTHighAI 8/10

Hercules Capital Provides Up to $150MM Strategic Credit Facility to Rocket Pharmaceuticals - News

Rocket Pharmaceuticals secured a $150M credit facility from Hercules Capital to support its cardiovascular pipeline, including a Phase 2 study for Danon disease. The facility provides up to $35M initially, with additional funds tied to milestones. Rocket expects current resources to fund operations into Q3 2028, extendable to 2029 with further borrowings.